130 related articles for article (PubMed ID: 6142647)
1. Adrenergic mechanisms in the control of plasma lipids in man.
Day JL; Metcalfe J; Simpson N; Lowenthal L
Am J Med; 1984 Feb; 76(2A):94-6. PubMed ID: 6142647
[TBL] [Abstract][Full Text] [Related]
2. Adrenergic mechanisms in control of plasma lipid concentrations.
Day JL; Metcalfe J; Simpson CN
Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1145-8. PubMed ID: 6122483
[TBL] [Abstract][Full Text] [Related]
3. [Antihypertensive therapy and lipid metabolism].
Krone W; Müller-Wieland D; Greten H
Klin Wochenschr; 1984 Mar; 62(5):193-202. PubMed ID: 6143851
[TBL] [Abstract][Full Text] [Related]
4. Effect of alpha- and beta-blocker therapy on blood lipids: European experience.
Leren P
Am J Med; 1984 Feb; 76(2A):67-71. PubMed ID: 6142644
[TBL] [Abstract][Full Text] [Related]
5. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
[TBL] [Abstract][Full Text] [Related]
6. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.
Leren P
Am J Med; 1987 Jan; 82(1A):31-5. PubMed ID: 2879461
[TBL] [Abstract][Full Text] [Related]
7. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
Goto Y
Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of beta-adrenoceptor blocking drugs with and without cardioselectivity and intrinsic sympathomimetic activity on lipoprotein metabolism in hypertriglyceridaemic patients and in normal men.
Durrington PN; Brownlee WC; Large DM
Clin Sci (Lond); 1985 Dec; 69(6):713-9. PubMed ID: 2866062
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.
Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M
Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656
[TBL] [Abstract][Full Text] [Related]
10. Effect of beta blockers on blood lipid profile.
Lehtonen A
Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
[TBL] [Abstract][Full Text] [Related]
11. Effects of beta-blockers on plasma lipids during antihypertensive therapy.
Lehtonen A
J Cardiovasc Pharmacol; 1985; 7 Suppl 2():S110-4. PubMed ID: 2409357
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment.
Rabkin SW
J Clin Pharmacol; 1993 Mar; 33(3):286-91. PubMed ID: 8096525
[TBL] [Abstract][Full Text] [Related]
13. Lipid effects of celiprolol, a new cardioselective beta-blocker, versus propranolol.
Sirtori CR; Johnson B; Vaccarino V; Montanari G; Cremoncini M; Gianfranceschi G; Sirtori M; Dujovne CA
Clin Pharmacol Ther; 1989 Jun; 45(6):617-26. PubMed ID: 2567218
[TBL] [Abstract][Full Text] [Related]
14. Free fatty acid metabolism during fenofibrate treatment of the metabolic syndrome.
Vega GL; Cater NB; Hadizadeh DR; Meguro S; Grundy SM
Clin Pharmacol Ther; 2003 Sep; 74(3):236-44. PubMed ID: 12966367
[TBL] [Abstract][Full Text] [Related]
15. Effects of adrenoceptor-blocking drugs on plasma lipoprotein concentrations.
Miller NE
Am J Cardiol; 1987 Sep; 60(9):17E-23E. PubMed ID: 2889350
[TBL] [Abstract][Full Text] [Related]
16. Effects of beta-blockers on the concentration and oxidizability of plasma lipids.
Dimmitt SB; Williams PD; Croft KD; Beilin LJ
Clin Sci (Lond); 1998 Jun; 94(6):573-8. PubMed ID: 9854453
[TBL] [Abstract][Full Text] [Related]
17. The relevance of intrinsic sympathomimetic activity for beta-blocker-induced changes in plasma lipids.
van Brummelen P
J Cardiovasc Pharmacol; 1983; 5 Suppl 1():S51-5. PubMed ID: 6188920
[TBL] [Abstract][Full Text] [Related]
18. Antihypertensive drugs and blood lipids: the Oslo study.
Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
[TBL] [Abstract][Full Text] [Related]
19. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
Eagles CJ; Kendall MJ
Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
[TBL] [Abstract][Full Text] [Related]
20. Influence of beta 2 agonism and beta 1 and beta 2 antagonism on adverse effects and plasma lipoproteins: results of a multicenter comparison of dilevalol and metoprolol.
Materson BJ; Vlachakis ND; Glasser SP; Lucas C; Ramanathan KB; Ahmad S; Morledge JH; Saunders E; Lutz LJ; Schnaper HW
Am J Cardiol; 1989 Jun; 63(19):58I-63I. PubMed ID: 2567113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
